Última atualização: Agosto 17, 2026
Promotion 2015 !
GMP certified manufacturers from Eastern Europe .
Prices in 3-4 times less .
List of drugs:
| Acetilcisteína, solution for inhalation | acetylcysteine | R05CB01 |
| 20% – 5 ml № 10 | ||
| aciclovir, powder for injection 1000 mg | aciclovir | J05AB01 |
| aciclovir, powder for injection 250 mg | aciclovir | J05AB01 |
| aciclovir, powder for injection 500 mg | aciclovir | J05AB01 |
| aciclovir, ointment 5% – 5,0 g | aciclovir | D06BB03 |
| aciclovir, comprimidos 200 mg № 20 | aciclovir | J05AB01 |
| Acidin-Pepsin, comprimidos 250 mg № 50 | betaine hydrochloride 0,2 g + pepsin 0,05 g | A09AC01 |
| Acidum ascorbinicum, 10 kg bag 10 % glicose | ascorbin acid | A11GA01 |
| Aerpicain, solutions for injection 2 ml № 10 | articaine+epinephrine | N01BB58 |
| Aevit, capsules 200 mg № 50 | retinol + tocopherol | A11JA |
| Allochol, coated tablets № 10 | activated charcoal+bile+urticae dioicae folia+allium sativum | A05AX |
| Allochol, coated tablets № 50 | activated charcoal+bile+urticae dioicae folia+allium sativum | A05AX |
| Amlodipina, comprimidos 5 mg №30 | amlodipine | C08CA01 |
| Ampicillin trihydrate, comprimidos 250 mg № 10 | ampicillin | J01CA01 |
| Ampicillin trihydrate, comprimidos 250 mg № 20 | ampicillin | J01CA01 |
| Analgin, comprimidos 500 mg № 10 | metamizole sodium | N02BB02 |
| Antioxidant complex (Vit A + Vit C+ Vit E) | ascorbic acid + tocopherol + retinol | A11JA |
| Antisclerol, capsules 300 mg № 25 | omega-3-triglycerides incl. other esters and acids | C10AX06 |
| Aspargitum, capsules 350 mg/50 mg №30 | arginine + acetylsalicylic acid | C05AX03 |
| Asparkam-L, solution for infusion 400 ml | potassium aspartate and magnesium aspartate | A12CX |
| Asparkam-L, solução injetável 5 ml № 5 | potassium aspartate and magnesium aspartate | A12CX |
| Atropine sulfate, solução injetável | atropine | A03BA01 |
| 0,1% – 1 ml № 10 | ||
| Azitromicina, capsules 250mg № 6 | azithromycin | J01FA10 |
| Butaminophen, ointment 2% – 3,0 g | butaminophen | D06BB |
| Butorphanol tartrate, solução injetável | butorphanol | N02AF01 |
| 0,2% – 1 ml № 10 | ||
| Butorphanol tartrate, solução injetável | butorphanol | N02AF01 |
| 0,2% – 1 ml № 5 | ||
| Cefalexina, capsules 250 mg № 10 | cefalexin | J01DA01 |
| Cefalexina, capsules 250 mg № 30 | cefalexin | J01DA01 |
| Cefazolin sodium, powder for injection | cefazolin | J01DA04 |
| 0,5 g № 1 | ||
| Cefazolin sodium, powder for injection | cefazolin | J01DA04 |
| 1,0 g № 1 | ||
| Cefepima, powder for injection 0,5 g № 1 | cefepime | J01DE01 |
| Cefepima, powder for injection 1,0 g № 1 | cefepime | J01DE01 |
| Cefotaxime sodium, powder for injection | cefotaxime | J01DD01 |
| 0,5 g № 1 | ||
| Cefotaxime sodium, powder for injection | cefotaxime | J01DD01 |
| 1,0 g № 1 | ||
| Ceftriaxone sodium, powder for injection | ceftriaxone | J01DD04 |
| 0,5 g № 1 | ||
| Ceftriaxone sodium, powder for injection | ceftriaxone | J01DD04 |
| 1,0 g № 1 | ||
| Celecoxibe, capsules 200mg №10 | celecoxib | M01AH01 |
| Cerebrolysat, solution for injection 1ml №10 | cerebrolysat | N06BX |
| nhondroitin sulfate | M01X25 | |
| nhondroitin sulfate | M01AX25 | |
| Cycloserine, capsules 250 mg №30 | cycloserine | J04AB01 |
| cilastatin + imipenem | J01DH51 | |
| cilastatin + imipenem | J01DH51 | |
| cilastatin + imipenem | J01DH51 | |
| cilastatin + imipenem | J01DH51 | |
| Ciprofloxacina, eye drops 0,3% – 5 ml № 1 | ciprofloxacin | S01AX13 |
| Ciprofloxacina, capsules 250mg № 10 | ciprofloxacin | J01MA02 |
| Ciprofloxacina, capsules 250mg № 20 | ciprofloxacin | J01MA02 |
| Ciprofloxacina, solution for infusions | ciprofloxacin | J01MA02 |
| 0,2% – 100 ml | ||
| Clophelin, comprimidos 0,15 mg № 50 | nlonidine | C02AC01 |
| Cocarboxylase hydrochloride, powder for injection 50 mg № 5 | nocarboxylase | A11DA |
| Corpo de vidro, solução injetável 2 ml № 10 | corpus vitreum | A16AX |
| Cynlophosphan, powder for injection 200 mg | cyclophosphamide | L01AA01 |
| Cotarabine, powder for injection 100 mg № 5 | nytarabine | L01BC01 |
| Cotarabine, powder for injection 1000 mg | nytarabine | L01BC01 |
| Cotarabine, solução injetável 2% – 5 ml № 5 | nytarabine | L01BC01 |
| D | ||
| Dalargina, solution for injections 0,1% 1ml №10 | dalarginium | A02BX |
| Dextrano 40, solution for infusion 100mg/ ml in bottle 400 ml | dextran | B05AA05 |
| Dextrano 60, solution for infusion 60mg/ ml in bottle 400 ml | dextran | B05AA05 |
| Dermaraef, ointment 15,0 g | bien | D11AX |
| Dexametasona, eye drops 0,1% – 1 ml № 2 in tube-dropping glass | dexamethasone | S01BA01 |
| Dexametasona, eye drops 0,1% – 5 ml № 1 | dexamethasone | S01BA01 |
| Dexametasona, solução injetável 0,4% – 1 ml № 10 | dexamethasone | H02AB02 |
| Dexametasona, solução injetável 0,4% – 2 ml № 10 | dexamethasone | H02AB02 |
| Diazepam, solution for injections 0,5% – 2ml №10 | diazepam | N05BA01 |
| Diclofenaco, comprimidos revestidos 25 mg № 30 | diclofenac | M01AB05 |
| Diclofenaco, eye drops 0,1% – 1 ml № 2 in tube-dropping glass | diclofenac | S01BC03 |
| Diclofenaco, eye drops 0,1% – 5 ml № 1 | diclofenac | S01BC03 |
| Diclofenac sodium, solução injetável 2,5% – 3ml 5 | diclofenac | M01AB05 |
| Diclopentil 50mg/100mg tablets № 30 | diclofenac + pentoxifylline | M01AB55 |
| Dimedrol, solução injetável 1% – 1 ml № 10 | diphenhydramine | R06AA02 |
| Dimedrol, comprimidos 50 mg № 10 | diphenhydramine | R06AA02 |
| Dimexid, gel 25% – 40,0 g | dimethylsulfoxide | M02AX03 |
| Dimexid, gel 50% – 40,0 g | dimethylsulfoxide | M02AX03 |
| Dithilin, solução injetável 2% – 5 ml № 10 | suxamethonium | M03AB01 |
| Doxorubicin hydrochlorid, powder for injection 10 mg | doxorubicin | L01DB01 |
| Doxycycline hydrochloride, capsules | doxycycline | J01AA02 |
| 100 mg № 10 | ||
| Droperidol, solução injetável | droperidol | N01AX01 |
| 0,25% – 5 ml № 10 | ||
| Drotaverine hydrochloride, solution for injections 20mg/ml №5 | drotaverine | A03AD02 |
| Drotaverine hydrochloride, comprimidos 40 mg № 10 | drotaverine | A03AD02 |
| E | ||
| Echingin, tablets № 20 | ginseng+ehinatseya | A13A |
| Emoxipin eye drops 1% – 5 ml № 1 | methylethylpiridinol | S01XA |
| Emoxipine, solution for infusion | emoxypine, methylethylpiridinol | N05N, S01XA |
| 0,5% – 100 ml № 1 | ||
| Emoxipine, solução injetável | emoxypine, methylethylpiridinol | N05N, S01XA |
| 1% – 1 ml № 10 | ||
| Emoxipine, solução injetável | emoxypine, methylethylpiridinol | N05N, S01XA |
| 3% – 10 ml № 1 | ||
| Emoxipine, solução injetável 3% – 5 ml № 5 | emoxypine, methylethylpiridinol | N05N, S01XA |
| Enalapril, comprimidos 10 mg №3 | enalapril | C09AA02 |
| F | ||
| coated tablets 20mg №30 | famotidine | A02BA03 |
| Fentanil, solução injetável | fentanyl | N02AB03 |
| 0,005% – 2 ml № 10 | ||
| comprimidos revestidos 300 mg №50 | ferous gluconate | B03AA |
| Fluconazol, solution for infusion 0,2% -100 ml | fluconazole | J02AC01 |
| 0,5 g № 5 | fludarabine | L01BB05 |
| Furosemida, 40 mg №50 | furosemide | C03CA01 |
| G | ||
| suspension 230,0 g | aluminium phosphate | A02AB03 |
| eye drops 1 ml № 2 in tube-dropping glass | gentamicin + dexamethasone | S01CA01 |
| Gentamicin sulfate, solução injetável | gentamicin | J01GB03 |
| 4% – 2 ml № 10 | ||
| Gentamicina, eye drops 0,3% – 1 ml in tube-dropping glass № 2 | gentamicin | S01AA11 |
| Gentamicina, hydrogel plate 0,1% – 6×9 centimeter | gentamicin | D06AX |
| Gentamicina, ointment 0,1% – 25,0g | gentamicin | D06AX07 |
| Glibenclamida, comprimidos 5 mg № 50 | glibenclamide | A10BB01 |
| comprimidos 100 mg № 40 | glycine | A16AA |
| H | ||
| Heparina, gel 1000 IU/1,0 g – 30 g | heparin sodium | C05BA03 |
| Heparina, ointment (with Benzocaine 0,04 g) 100 IU/1,0g – 25 g | heparin sodium + benzocaine + benzylnicotinate | C05BA53 |
| Heparina, solução injetável | heparin | B01AB01 |
| 5000 IU/1 ml – 5 ml № 5 | ||
| Hidrocortisona, ointment 1% – 10,0 g | hydrocortisone | D07AA02 |
| Hydroxyapatite, gel, syringe 1 g | hydroxyapatite | M02 |
| Hydroxyapatite, gel, syringe 2 g | hydroxyapatite | M02 |
| Hydroxyapatite, gel, syringe 5 g | hydroxyapatite | M02 |
| Hydroxycarbamide, capsules 250 mg № 10 | hydroxycarbamide | L01XX05 |
| EU | ||
| Ibuprofeno, comprimidos revestidos 200 mg № 50 | ibuprofen | M01AE01 |
| Ibuprofeno, ointment 5% – 15 g | ibuprofen | M02AA13 |
| Insulin-long PMC, suspension for injection 100UI/1ml in vial | insulina (carne de porco) | A10AC03 |
| Insulin-semilong PMC, suspension for injection 100UI/1ml in vial | insulina (carne de porco) | A10AC03 |
| K | ||
| Cetotifeno, comprimidos 1 mg № 30 | ketotifen | R06AX17 |
| eu | ||
| Lactobacillin, powder 5 dose in vials № 6 | lactobacillus acidophilus | A07FA01 |
| Laevomycetin, capsules 250 mg № 10 | chloramphenicol | J01BA01 |
| Laevomycetin, capsules 250 mg № 20 | chloramphenicol | J01BA01 |
| Laevomycetin, eye drops 0,25% – 10 ml | chloramphenicol | S01AA01 |
| Laevomycetin, comprimidos 500 mg № 20 | chloramphenicol | J01BA01 |
| Leucladin, solução injetável | nladribine | L01BB04 |
| 0,1% – 10 ml № 1 | ||
| Leucladin, solução injetável 0,1% – 5 ml № 5 | nladribine | L01BB04 |
| Levofloxacino, capsules 250 mg №10 | levofloxacin | S01AX19 |
| Levofloxacino, eye drops 0,5 % – 1 ml № 2 in tube-dropping glass | levofloxacin | S01AX19 |
| Levofloxacino, eye drops 0,5% – 5 ml | levofloxacin | S01AX19 |
| Levofloxacino, solution for infusions | levofloxacin | J01MA12 |
| 0,5% – 100 ml № 1 | ||
| Levothyroxine sodium, 0,1mg №50 | levothyroxine | H03AA01 |
| Lidocaine hydrochloride, solução injetável 2% – 2 ml № 10 | lidocaine | C01BB01 |
| Lincomycin hydrochlorid, capsules | lincomycin | J01FF02 |
| 250 mg № 20 | ||
| Lincomycin hydrochlorid, solução injetável 30% – 1 ml № 10 | lincomycin | J01FF02 |
| Loratadine, comprimidos 10 mg № 20 | loratadine | R06AX13 |
| Lydaza, powder for injection 64 IU in vials № 5 | hyaluronidase | B06AA03 |
| M | ||
| Mannit, solution for infusion 15% – 400 ml in bottle | mannitol | B05BC01 |
| Melanin, (Melanin 0,5 mg + Bien 50 mg) ointment 0,05% – 15,0 g | melanin + bien | D02BA |
| Mercaptopurine, comprimidos 50 mg № 50 | mercaptopurine | L01BB02 |
| Meropenem, powder for injection 0,5 g | meropenem | J01DH02 |
| Meropenem, powder for injection 1,0 g | meropenem | J01DH02 |
| Methotrexate, comprimidos revestidos 2,5 mg № 20 | methotrexate | L01BA01 |
| Methotrexate, comprimidos revestidos 5 mg № 20 | methotrexate | L01BA01 |
| Methotrexate, powder for injection 0,01 g № 5 | methotrexate | L01BA01 |
| Methotrexate, powder for injection 0,05 g № 5 | methotrexate | L01BA01 |
| Metronidazole, gel 1% – 18 g | metronidazole | D06BX01 |
| Metronidazole, solution for infusions | metronidazole | J01XD01 |
| 0,5% – 100 ml | ||
| Metronidazole, comprimidos 250 mg № 10 | metronidazole | J01XD01 |
| comprimidos revestidos 125 mg № 30 | mexidol | N07XX |
| solution for infusion 0,2% 100 ml | mexidol | N07XX |
| , solução injetável 5% – 2 ml № 10 | mexidol | N07XX |
| solução injetável | meldonium | A14B |
| 10% – 5 ml № 10 | ||
| Monoinsulin HS, solução injetável | insulina (humano) | A10AB01 |
| 100 UI/1ml – 10 ml in vial | ||
| Monolong, capsules 40 mg №30 | isosorbide mononitrte | C01DA14 |
| Morphine hydrochlorid, solution for injections 1% №10 | morphine | N02AA01 |
| capsules 250 mg №20 | nhondroitin sulfate | M01AX25 |
| solução injetável 2 ml № 10 | nhondroitin sulfate | M01AX25 |
| syrup 80 ml | carbocisteine | R05CB03 |
| Myramistin, hydrogel plates 0,05% 6×9 centimeter №1 | myramistin | D08AJ |
| solution for infusion 400 ml in bottle | dextran (62500±7500) | B05AA05 |
| syrup 10mg/5ml, 80ml №1 | dicycloverine | A03AA07 |
| Novocainamid, solução injetável | procainamide | C01BA02 |
| 10% – 5 ml № 5 | ||
| comprimidos 5 mg №20 | oxybutynin | G04BD04 |
| ointment 5% – 5,0 g | cyclocitidine monophosfate | D06BB |
| ophthalmic ointment 3,0 g | cyclocitidine monophosfate | S01AD |
| ophthalmic ointment 5,0 g | cyclocitidine monophosfate | S01AD |
| Nystatin, comprimidos revestidos 500 000 IU № 20 | nystatin | A07AA02 |
| Nystatin, ointment 100 000 IU/1,0 g – 25,0 g | nystatin | D01AA01 |
| solution for injections 5ml | ovomukoid – glycoprotein duck eggs | B02AB |
| Oxaliplatin, powder for infusion 50mg | oxaliplatin | L01XA03 |
| Oxoline, ointment 0,25% 15g | oxolin | D06BB |
| P | ||
| Paclitaxel, concentrat for prepare solution for infusion 6mg/ml – 5 ml | paclitaxel | L01CD01 |
| Paclitaxel, concentrat for prepare solution for infusion 100mg/16,7ml | paclitaxel | L01CD01 |
| coated tablets 2,5mg №30 | indapamide | C03BA11 |
| Pancreatina, comprimidos revestidos 25 IU № 50 | multienzymes (lipase, protease etc.) | A09AA02 |
| tablets №10 | paracetamol+acidum acetylsalicylicum+coffein | N02BA51 |
| PASK Sodium 12 g № 10 | aminosalicylate sodium | J04AA02 |
| PASK Sodium, powder for infusion 3 g – 100 ml | aminosalicylate sodium | J04AA02 |
| Pentalgin-N, tablets №10 | codeine+caffeine+metamizole sodium+naproxen+phenobarbital | N02BB72 |
| Pentalgin-N, tablets №20 | codeine+caffeine+metamizole sodium+naproxen+phenobarbital | N02BB72 |
| Fenibute, comprimidos 250 mg № 10 | phenibut | N05BX |
| Fenibute, comprimidos 250 mg № 20 | phenibut | N05BX |
| Fenobarbital, comprimidos 100 mg № 12 | phenobarbital | N03AA02 |
| powder for injection 100 mg | photolon | L01XD |
| Phytonsol, tablets №20 | ginseng+liquorice | A13A |
| Pilocarpine hydrochloride, eye drops 1% – 1 ml № 10 in tube-dropping glass | pilocarpine | S01EB01 |
| Piracetam, capsules 400 mg № 30 | piracetam | N06BX03 |
| Piracetam, solução injetável | piracetam | N06BX03 |
| 20% – 5 ml № 10 | ||
| tablets №10 | codeine+caffeine+metamizole sodium+naproxen+phenobarbital | N02BB72 |
| Polyglucin, solution for infusion 400 ml | dextran (50000-70000) | B05AA05 |
| in bottle № 1 | ||
| capsules 50 mg №2 | sildenafila | G04BE03 |
| Orotato de potássio, comprimidos 500 mg № 10 | potassium oratate | C01EB |
| Prednisolona, ointment 0,5% – 10 g | prednisolone | D07AA03 |
| Prednisolona, tablets 5mg № 50 | prednisolone | H02AB06 |
| Predsatine, powder for infusion 5mg №5 | prostate extract | G04BX |
| Promedol, solução injetável 2% – 1 ml № 10 | trimeperidin hydrochloride | N02AB |
| Protamin-insulin HS, suspension for injection 100 UI/1ml – 10 ml in vial | insulina (humano) | A10AE01 |
| Proxodolol, eye drops 1% – 1 ml № 10 in tube-dropping glass | proxodolol | S01ED |
| P | ||
| solução injetável 400 ml in bottle | potassium chloride + calcium chloride + magnesium chloride + sodium acetate + cloreto de sódio | B05BB01 |
| R | ||
| Remantadin, comprimidos 50 mg № 10 | rimantadine | J05AC02 |
| Remantadin, comprimidos 50 mg № 20 | rimantadine | J05AC02 |
| Reparaef-1, ointment 15 g | bien | D03 |
| Reparaef-2, ointment 15 g | bien | D03 |
| Retinoli acetas, oily solution in capsules | retinol | A11CA01 |
| 33 000 IU № 50 | ||
| Retinoli acetas, oily solution in capsules | retinol | A11CA01 |
| 5 000 IU № 50 | ||
| Rheogluman , solution for infusion 400ml | dextran+mannitol+sodium chloride | B05AA05 |
| Rheopolyglucin, solution for infusion | dextran (30000-40000) | B05AA05 |
| 200 ml bottle | ||
| Rheopolyglucin, solution for infusion | dextran (30000-40000) | B05AA05 |
| 400 ml bottle | ||
| Riboxin, covered tablets 200 mg № 50 | inosine | C01EB |
| Rifampicina, capsules 150 mg № 20 | rifampicina | J04AB02 |
| Rifampicina, powder for injection 150 mg №10 | rifampicina | J04AB02 |
| solution for infusion 6% 400ml | dextran (60000) | B03AE10 |
| R tablets №50 | ascorbic acid+rutoside | C05CA51 |
| S | ||
| tablets 0,4mg №30 | sodium selenite | A12CE |
| solution 0,01% 100ml | myramistin | D08AJ |
| eye drops/drops in the nose №2 | carnosin | S01XA |
| eye drops/drops in the nose 5ml | carnosin | S01XA |
| Sodium nucleinate, capsules 100 mg № 30 | sodium nucleinate | L03AX |
| Sormantol, solution for infusion 400ml | sorbitol +mannitol + cloreto de sódio | B05BC01 |
| Speisferron, solution for injections 5ml №10 | dextriferron | B03XA |
| Streptokinase 1 500 000 IU in vial | estreptoquinase | B01AD01 |
| Streptokinase 750 000 IU in vial | estreptoquinase | B01AD01 |
| Sulfacyl sodium, eye drops 20% – 5 ml № 1 | sulfacetamide | S01AB04 |
| Sulfacyl sodium, eye drops 20% in tube-dropping glass 1 ml № 2 | sulfacetamide | S01AB04 |
| Sulfacyl sodium, eye drops 30% – 5 ml № 1 | sulfacetamide | S01AB04 |
| T | ||
| eye drops 4% – 5 ml № 1 | taurine | S01X |
| Terbinafine, cream 1% – 15,0 g | erbinafine | D01AE15 |
| Terbinafine, comprimidos 250 mg №10 | terbinafine | D01BA02 |
| Tetracycline, comprimidos revestidos 100 mg № 10 | tetracycline | J01AA07 |
| Tetracycline, comprimidos revestidos 100 mg № 20 | tetracycline | J01AA07 |
| Thymalin, powder for injection 10 mg № 5 | thymalinum | L03AX |
| Timolol, eye drops 0,25% – 1 ml № 2 in tube-dropping glass | timolol | S01ED01 |
| Timolol, eye drops 0,5% – 1 ml № 2 in tube-dropping glass | timolol | S01ED01 |
| Timolol, eye drops 0,5% – 5 ml № 2 | timolol | S01ED01 |
| Tramadol, solução injetável 5% – 1 ml № 10 | tramadol | N02AX02 |
| Tramadol, solução injetável 5% – 2 ml № 10 | tramadol | N02AX02 |
| Tricardin, capsules №20 | valerian+hawthorn+leonur | N05CM |
| Trimetazidine, comprimidos 20 mg №30 | trimetazidine | C01EB15 |
| Trimunal, tablets №20 | ginseng+liquorice+ehinatseya | A13A |
| Tropisetron, capsules 5 mg №6 | tropisetron | A04AA03 |
| Tropisetron, solução injetável | tropisetron | A04AA03 |
| 0,1% 5 il № 5 | ||
| Você | ||
| Unitol, solução injetável 5% – 5 ml №10 | dimercaptopropansulfonate sodium | V03AX |
| V | ||
| Vancomycin, freeze-dried powder for infusion 1000 mg №40 | vancomycin | J01XA01> |
| Verapamil hydrochloride, comprimidos revestidos | verapamil | C08DA01 |
| 80 mg № 50 | ||
| eye drops 1 ml № 2 em | adenosina + nicotinic acid + calcium chloride + magnesium chloride | S01XA |
| tube-dropping glass | ||
| Z | ||
| Zinci sulfas 0,25% and Anid borici 2% – 1 ml № 2 eye drop in tube-dropping glass | boric acid + zinc sulfate | S01XA |
| Zoledronic acid, powder for injection 4 mg | zoledronic acid | M05BA08 |
| α | ||
| α-Tocopheroli acetas, 50% oily solution in capsules 100 mg № 30 | tocopherol | |
Revisão de Caso Científico
Você gostaria de entender se os programas clínicos atuais, desenvolvimentos de pesquisa recentes, ou abordagens emergentes podem ser relevante para sua situação individual?
Envie sua dúvida para nossa equipe científica. A sede da NBScience no Reino Unido coordena consultas em toda a rede internacional de centros médicos, cientistas, e consultores especializados.
- Revisão das informações que você fornece
- Informações relevantes sobre pesquisas e programas clínicos
- Uma resposta clara focada na sua situação
O que acontece a seguir?
Envie sua pergunta, receber uma revisão científica focada, e obter uma resposta clara sobre pesquisas e programas clínicos relevantes para sua situação.
Sua revisão científica será preparada por Dr.. Helen Melnik,Doutorado , quem tem mais de 25 anos de experiência em pesquisa com células-tronco e programas clínicos internacionais.
Sem obrigação. Sua pergunta será analisada confidencialmente.
Apenas informações educacionais e de pesquisa. Este serviço não constituem aconselhamento médico, diagnóstico, prescrição, ou um personalizado recomendação de tratamento.
